Wealth Enhancement Advisory Services’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88.3K Buy
29,535
+14,982
+103% +$64.9K ﹤0.01% 3340
2025
Q4
$58.4K Buy
14,553
+3,068
+27% +$18.8K ﹤0.01% 3523
2025
Q3
$112K Sell
11,485
-5,820
-34% -$59K ﹤0.01% 3313
2025
Q2
$187K Sell
17,305
-5,323
-24% -$45.4K ﹤0.01% 3016
2025
Q1
$194K Sell
22,628
-4,045
-15% -$38.2K ﹤0.01% 2638
2024
Q4
$286K Buy
26,673
+10,925
+69% +$84K ﹤0.01% 2421
2024
Q3
$89.4K Buy
15,748
+1,246
+9% +$7.19K ﹤0.01% 2577
2024
Q2
$61.2K Buy
14,502
+422
+3% +$1.71K ﹤0.01% 2444
2024
Q1
$71.7K Buy
14,080
+1,289
+10% +$7.26K ﹤0.01% 2323
2023
Q4
$119K Buy
12,791
+1,916
+18% +$13.2K ﹤0.01% 2155
2023
Q3
$71.2K Buy
+10,875
New +$86.6K ﹤0.01% 2134

Other funds holding AVXL